Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mindbio Therapeutics Corp. (TSE:MBIO)
CNQX:MBIO
Mindbio Therapeutics Corp. (MBIO) Stock Price & Analysis
8 Followers
MBIO Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.14
Previous CloseC$0.07
Volume46.35K
Average Volume (3M)43.48K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)AU$116.75K
Total Debt (Recent Filing)AU$5.00M
Price to Earnings (P/E)-2.9
Beta0.44
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding133,047,305
10 Day Avg. Volume36,194
30 Day Avg. Volume43,480
Standard Deviation0.50
R-Squared0.01
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-1.41
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio25.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mindbio Therapeutics Corp. News
PremiumCompany Announcements
MindBio Inks Major Deal on Psychedelic Prodrug
PremiumCompany Announcements
MindBio Advances Mental Health TreatmentsPremiumCompany Announcements
MindBio Eyes Senior Exchange Amidst Promising Trials
PremiumCompany Announcements
MindBio Launches Pioneering Women’s Health Drug Trials
PremiumCompany Announcements
MindBio’s Psychedelic Treatment Improves Sleep
PremiumCompany Announcements
MindBio Therapeutics Expands Shareholder Base
PremiumCompany Announcements
MindBio Launches Pioneering Depression Microdosing TrialPremiumCompany Announcements
MindBio Advances Landmark Depression Microdosing TrialMBIO FAQ
What was Mindbio Therapeutics Corp.’s price range in the past 12 months?
Mindbio Therapeutics Corp. lowest stock price was C$0.01 and its highest was C$0.14 in the past 12 months.
What is Mindbio Therapeutics Corp.’s market cap?
Currently, no data Available
When is Mindbio Therapeutics Corp.’s upcoming earnings report date?
Mindbio Therapeutics Corp.’s upcoming earnings report date is May 13, 2024 which is 3 days ago.
How were Mindbio Therapeutics Corp.’s earnings last quarter?
Mindbio Therapeutics Corp. released its earnings results on Feb 08, 2024. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is Mindbio Therapeutics Corp. overvalued?
According to Wall Street analysts Mindbio Therapeutics Corp.’s price is currently Overvalued.
Does Mindbio Therapeutics Corp. pay dividends?
Mindbio Therapeutics Corp. does not currently pay dividends.
What is Mindbio Therapeutics Corp.’s EPS estimate?
Mindbio Therapeutics Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mindbio Therapeutics Corp. have?
Mindbio Therapeutics Corp. has 133,047,300 shares outstanding.
What happened to Mindbio Therapeutics Corp.’s price movement after its last earnings report?
Mindbio Therapeutics Corp. reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Mindbio Therapeutics Corp.?
Currently, no hedge funds are holding shares in TSE:MBIO
---
Mindbio Therapeutics Corp. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-41.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-64.23%
Trailing 12-Months
Company Description
Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. operates as a clinical stage drug development company. It is involved in the clinical research into the microdosing of psychedelic medicines to treat a range of medical conditions, such as depression, anxiety, PTSD, panic disorder, chronic pain, and opiate addictions. The company is based in Melbourne, Australia.
---
Technical Analysis
---